Article
Metabolic syndrome marks early risk for cognitive decline with APOE4 gene variation: A case study.
Diabetes & metabolic syndrome - 1 Sept 2018
Brown Dawson, Gibas Kelly J
Abstract excerpt
A vast amount of research has been done on the APOE4 genetic marker for Alzheimer's disease (AD), but its connection to metabolic processes associated with peripheral insulin resistance and cerebral glucose metabolism is still relatively unknown. The APOE4 allele is the strongest genetic risk factor for developing late-onset Alzheimer's disease, particularly in individuals who have inherited two copies of the...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
